OptiBiotix Health PLC
LSE:OPTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
OptiBiotix Health PLC (OPTI) under the Base Case is 2.25 GBX per share.
Compared with the current market price of 4.55 GBX, the stock appears
Overvalued by 50% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -334% last year to 19% by 2031. Revenue grows about -1% a year over the next five years, after falling about 5% a year over the last five years.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What OptiBiotix Health Does
OptiBiotix Health Plc engages in the identification and development of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds. The company is headquartered in Heslington, York and currently employs 5 full-time employees. The company went IPO on 2011-09-09. The firm is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements.
- Headquarters
- United Kingdom UK
- Employees
- 5
- IPO date
- Sep 9, 2011
Earnings Waterfall
OptiBiotix Health PLC
What is the Intrinsic Value of one OPTI stock?
The intrinsic value for OptiBiotix Health PLC (OPTI) under the Base Case is 2.25 GBX.
Is OPTI stock undervalued or overvalued?
Compared with the current market price of 4.55 GBX, the stock appears Overvalued by 50% .
